503 Overzicht aandelen
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People’s Republic of China and Hong Kong.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 1/6 |
Lansen Pharmaceutical Holdings Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | HK$1.79 |
| 52 Week Hoogtepunt | HK$1.82 |
| 52 Week Laag | HK$1.20 |
| Bèta | 0.92 |
| 11 maand verandering | 3.47% |
| 3 maanden verandering | 5.92% |
| 1 Jaar Verandering | 23.58% |
| 33 jaar verandering | 5.92% |
| 5 jaar verandering | 101.48% |
| Verandering sinds IPO | -59.35% |
Recent nieuws en updates
Recent updates
Does Lansen Pharmaceutical Holdings (HKG:503) Have A Healthy Balance Sheet?
Sep 18
Is Lansen Pharmaceutical Holdings (HKG:503) Using Too Much Debt?
Mar 27Lansen Pharmaceutical Holdings (HKG:503) Has A Rock Solid Balance Sheet
Sep 27Is Lansen Pharmaceutical Holdings (HKG:503) A Risky Investment?
Dec 06Is Lansen Pharmaceutical Holdings (HKG:503) A Risky Investment?
Sep 04We're Not So Sure You Should Rely on Lansen Pharmaceutical Holdings's (HKG:503) Statutory Earnings
Dec 28
Rendement voor aandeelhouders
| 503 | HK Pharmaceuticals | HK Markt | |
|---|---|---|---|
| 7D | 0% | -7.2% | -1.0% |
| 1Y | 23.6% | -2.9% | 15.0% |
Rendement versus industrie: 503 exceeded the Hong Kong Pharmaceuticals industry which returned -10.6% over the past year.
Rendement versus markt: 503 exceeded the Hong Kong Market which returned -11.4% over the past year.
Prijsvolatiliteit
| 503 volatility | |
|---|---|
| 503 Average Weekly Movement | 16.3% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stabiele aandelenkoers: 503's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: 503's weekly volatility has increased from 10% to 16% over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2001 | 652 | Li Chen | www.lansen.com.cn |
Lansen Pharmaceutical Holdings Limited Samenvatting
| 503 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | HK$750.60m |
| Inkomsten(TTM) | HK$57.82m |
| Inkomsten(TTM) | HK$506.62m |
13.0x
Koers/Winstverhouding1.5x
P/S-verhoudingIs 503 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 503 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$64.95m |
| Kosten van inkomsten | US$22.05m |
| Brutowinst | US$42.90m |
| Overige uitgaven | US$35.49m |
| Inkomsten | US$7.41m |
Laatst gerapporteerde inkomsten
Jun 30, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.018 |
| Brutomarge | 66.05% |
| Nettowinstmarge | 11.41% |
| Schuld/Eigen Vermogen Verhouding | 14.2% |
Hoe presteerde 503 op de lange termijn?
Bekijk historische prestaties en vergelijking